MedImmune Incorporated

WASHINGTON (AP) _ Just about everybody needs a flu vaccine — unless you're an infant or a healthy adult hermit — but far too few of the Americans who need protection the most get it. That's the message as flu-shot season officially began...

For the new child-based, flu-control strategy to work, families of children ages 5 to 18 must embrace the recommendation. And that won't happen easily. Cost is not likely to be an obstacle -- flu shots cost only about $20 to $30 at the lowest-cost...

Micromet Inc.'s experimental cancer treatment shrank tumors in people with non-Hodgkin's lymphoma in a study that might lead to a new approach in tackling malignant diseases. The medicine, called blinatumomab, caused complete or partial tumor...

Stocks rebounded Thursday amid corporate takeover speculation. Among the day's buyout rumors were Chicago-based commercial printer R.R. Donnelley, health-care products-maker MedImmune and nursing home operator Manor Care. Wall Street feeds on buyout...

Monday: -- Earnings: American Express Co.; Amgen Inc.; AT&T Inc.; First Data Corp.; Ford Motor Co.; Halliburton Co.; Hasbro Inc.; Kimberly-Clark Corp.; Kraft Foods Inc.; National Instruments Corp.; Pactiv Corp.; Rockwell Automation Inc.; Texas Instruments...

WASHINGTON - MedImmune Inc. must stop using a marketing brochure for FluMist, its nasal-spray influenza vaccine, because the document lacks directions for use and details on potential risks, federal regulators said. "This consumer-directed flier is...

Executives and board members at some of Maryland's most profitable companies have lucrative side arrangements with the companies they run and oversee. Edwin F. Hale Sr., the chairman, chief executive and largest stockholder at First Mariner Bancorp,...

At first glance, Nolan D. Archibald might seem like a perfect example for critics of runaway executive pay. The chief executive of Black & Decker Corp. pulled in a base salary of nearly $1.5 million and a bonus of $3 million last year while...

The company whose contaminated plant touched off last year's flu vaccine shortage said yesterday that it won't be able to make all the doses promised for the 2005-2006 influenza season, raising the possibility of another vaccine shortage this fall....

Though flu season is not over, a report by one Wall Street analyst suggests sales of FluMist, the nasal spray flu vaccine made by Gaithersburg-based MedImmune Inc., will again be dismal this year. Survey results released this week by the New York...

A number of Maryland's biotechnology companies will have prospective new drugs in their final round of clinical testing this year, a key stage for some in their efforts to fully evolve from research organizations into market-driven businesses....

The biotechnology industry raked in billions of dollars from investors last year as it basked in the spotlight of one of science's great achievements, the sequencing of the human genome. This year, investors will expect the industry to show what can be...